Analysis of Plasma Epstein–Barr Virus DNA and Clinical Outcomes to Pembrolizumab or Chemotherapy in Recurrent/Metastatic Nasopharyngeal Cancer in KEYNOTE‐122.
Saved in:
| Title: | Analysis of Plasma Epstein–Barr Virus DNA and Clinical Outcomes to Pembrolizumab or Chemotherapy in Recurrent/Metastatic Nasopharyngeal Cancer in KEYNOTE‐122. |
|---|---|
| Authors: | Chan, Anthony T. C.1 (AUTHOR) anthonytcchan@cuhk.edu.hk, Lee, Victor Ho Fun2 (AUTHOR), Hong, Ruey‐Long3 (AUTHOR), Ahn, Myung‐Ju4 (AUTHOR), Chong, Wan Qin5 (AUTHOR), Spreafico, Anna6 (AUTHOR), Kim, Sung‐Bae7 (AUTHOR), Ho, Gwo Fuang8 (AUTHOR), Caguioa, Priscilla B.9 (AUTHOR), Ngamphaiboon, Nuttapong10 (AUTHOR), Swaby, Ramona F.11 (AUTHOR), Wei, Bo11 (AUTHOR), Webber, Andrea L.11 (AUTHOR), Kang, John11 (AUTHOR), Gumuscu, Burak11 (AUTHOR), Yuan, Jianda11 (AUTHOR), Siu, Lillian L.6 (AUTHOR) |
| Source: | Cancer Medicine. Feb2026, Vol. 15 Issue 2, p1-9. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
